Search results
FDA investigating cancer risk linked to CAR-T cell therapy
BioPharma Dive via Yahoo Finance· 7 months agoThe Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’...
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 7 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
Bristol Myers (BMY) Announces CAR T Cell Therapy Breyanzi Data
Zacks via Yahoo Finance· 12 months agoBristol Myers' (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel) shows deep and durable...
FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
CNN via Yahoo News· 5 months agoThe US Food and Drug Administration has issued a new warning about the possible risk of secondary...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst at GlobalData. At the...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 4 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 7 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Zacks via Yahoo Finance· 1 year agoGilead Sciences’ GILD Kite announced encouraging three-year follow-up results from the ZUMA-3 study...
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of...
Benzinga via Yahoo Finance· 2 years agoThe European Commission approved Kite Pharma's, a Gilead Sciences Inc (NASDAQ: GILD) Yescarta...
FDA says cancer treatment CAR-T therapy may cause cancer itself
Newsy via AOL· 5 months agoGrowing bacteria to create CAR-T therapy The Food and Drug Administration will require companies...